NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: InnovaSystems, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

InnovaSystems Launches A New Actuator for Testing of Nasal Spray Products - InnovaSystems introduces the newest member of it's actuator family; the NSP Universal Actuator - InnovaSystems.com
InnovaSystems Launches A New Actuator for Testing of Nasal Spray Products

 

NewswireToday - /newswire/ - Moorestown, NJ, United States, 2010/05/27 - InnovaSystems introduces the newest member of it's actuator family; the NSP Universal Actuator - InnovaSystems.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The NSP Universal Actuator (NSP UA) was well received during its debut at RDD 2010. It’s burgundy, steel and black motif caught the eye of visitors but the innovative color scheme isn’t all that makes the NSP UA stand out.

The NSP UA is the newest member of InnovaSystems’ family of NSP actuators. Our actuators automate the routine actuation of Nasal Spray Products and Metered Dose Inhaler Products for performing FDA Recommended Tests.

Historically, actuators offered only a single mode of operation. For example; InnovaSystems’ Mighty Runt Actuation Station actuates the product by applying a controlled force while the NSP Velocity Actuator (NSP VA) actuates the product at a specified velocity. The new NSP UA uses Linear Motor Technology which enables user selectable Velocity or Force mode of actuation, while providing superior accuracy and reliability.

The NSP UA is easy-to-use; just place the bottle on the platform, select a stored product and start. To aide commissioning, actuation parameters from InnovaSystems’ Mighty Runt and NSP VA Actuators are easily transferred to the NSP UA.

The NSP UA monitors the actual velocity or force and distance of each actuation. Actuations are highly reproducible and monitored with user definable Pass / Fail criteria. The NSP UA provides graphical views of Live or historical actuation data. Force / Travel and Energy / Travel graphs are provided. Users may isolate single actuation profiles and compare them against other actuations. Data may also be output to a Comma Separated Values (CSV) file or to a Portable Document File (PDF).

The NSP UA supports 21CFR Part 11 Compliance and simplifies validation with IQ/OQ documentation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: InnovaSystems, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


InnovaSystems Launches A New Actuator for Testing of Nasal Spray Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Richard Sellers - InnovaSystems.com 
856-722-0410 rsellers[.]innovasystems.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any InnovaSystems, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From InnovaSystems, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050 - A Novel Individualized Neoantigen Cancer Vaccine
DSM Plans New Production Site for Bovaer® in Dalry, Scotland
Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)